MTOR inhibitor-associated stomatitis (mIAS) in three patients with cancer treated with everolimus

Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology

Volumn 119, Issue 1, 2015, Pages e13-e19

  Kalogirou, Eleni Marina ^a   Tosios, Konstantinos I ^a   Piperi, Evangelia P ^a   Sklavounou, Alexandra ^a  

^a UNIVERSITY OF ATHENS   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; EVEROLIMUS; RAPAMYCIN;

AGED; ANALOGS AND DERIVATIVES; BREAST NEOPLASMS; CARCINOMA, RENAL CELL; CASE REPORT; CHEMICALLY INDUCED; FEMALE; HUMAN; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; STOMATITIS;

AGED; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CARCINOMA, RENAL CELL; EVEROLIMUS; FEMALE; HUMANS; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; SIROLIMUS; STOMATITIS;

EID: 84915748234     PISSN: 22124403     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.oooo.2014.08.023     Document Type: Article

References (29)

1. F. Martins, M.A. de Oliveira, and Q. Wang A review of oral toxicity associated with mTOR inhibitor therapy in cancer patients Oral Oncol 49 2013 293 298
2. M.A. de Oliveira, F. Martins e Martins, and Q. Wang Clinical presentation and management of mTOR inhibitor-associated stomatitis Oral Oncol 47 2011 998 1003
3. C. Ferté, A. Paci, and M. Zizi Natural history, management and pharmacokinetics of everolimus-induced-oral ulcers: insights into compliance issues Eur J Cancer 47 2011 2249 2255
4. Novartis. Afinitor; (everolimus) [prescribing information]. Available at: http://www.pharma.us.novartis.com/product/pi/pdf/afinitor.pdf. Accessed August 9, 2014.
5. C.B. Boers-Doets, J.E. Raber-Durlacher, and N.S. Treister Mammalian target of rapamycin inhibitor-associated stomatitis Future Oncol 9 2013 1883 1892
6. S. Sonis, N. Treister, S. Chawla, G. Demetri, and F. Haluska Preliminary characterization of oral lesions associated with inhibitors of mammalian target of rapamycin in cancer patients Cancer 116 2010 210 215
7. National Cancer Institute. Oral complications of chemotherapy and head/neck radiation (PDQ). Oral Mucositis Available at: http://www.cancer.gov/-cancertopics/pdq/supportivecare/oralcomplications/HealthProfessional/page5. Accessed August 9, 2014.
8. C.B. Boers-Doets, J.B. Epstein, and J.E. Raber-Durlacher Oral adverse events associated with tyrosine kinase and mammalian target of rapamycin inhibitors in renal cell carcinoma: a structured literature review Oncologist 17 2012 135 144
9. O. Nicolatou-Galitis, A. Nikolaidi, I. Athanassiadis, E. Papadopoulou, and S. Sonis Oral ulcers in patients with advanced breast cancer receiving everolimus: a case series report on clinical presentation and management Oral Surg Oral Med Oral Pathol Oral Radiol 116 2013 110 116
10. O. Nicolatou-Galitis, D. Bafaloukos, and G. Manolakis Oral ulcers in cancer patients who receive mTOR inhibitors: an emerging oral toxicity Mediterranean Oncol J 2 2012 50 56
11. J.M. Campistol, J.W. de Fijter, S.M. Flechner, A. Langone, E. Morelon, and E. Stockfleth mTOR inhibitor-associated dermatologic and mucosal problems Clin Transplant 24 2010 149 156
12. A.P. Pilotte, M.B. Hohos, K.M. Polson, T.M. Huftalen, and N. Treister Managing stomatitis in patients treated with mammalian target of rapamycin inhibitors Clin J Oncol Nurs 15 2011 83 89
13. C. Porta, S. Osanto, and A. Ravaud Management of adverse events associated with the use of everolimus in patients with advanced renal cell carcinoma Eur J Cancer 47 2011 1287 1298
14. Common Terminology Criteria for Adverse Events v3.0 (CTCAE), Version 3.0 August 9, 2006 Cancer Therapy Evaluation Program, August 9, 2006 Bethesda, MD Available at: http://ctep.cancer.gov/protocolDevelopment/electronic-applications/docs/ctcaev3.pdf Accessed August 9, 2014
15. T. Sasaoka, T.S. Kato, and N. Oda Common occurrence of everolimus-associated aphthous stomatitis in Japanese heart transplant recipients Transplant Proc 42 2010 3700 3703
16. A. O'Donnell, S. Faivre, and H.A. Burris III Phase I pharmacokinetic and pharmacodynamic study of the oral mammalian target of rapamycin inhibitor everolimus in patients with advanced solid tumors J Clin Oncol 26 2008 1588 1595
17. S.O. Akintoye, and M.O. Greenberg Recurrent aphthous stomatitis Dent Clin North Am 49 2005 31 47
18. M. Aapro, F. Andre, and K. Blackwell Adverse event management in patients with advanced cancer receiving oral everolimus: focus on breast cancer Ann Oncol 25 2014 763 773
19. J. Divers Management of stomatitis associated with mTOR inhibitors in hormone receptor-positive/HER-2 negative advanced breast cancer: clinical experience from a single center Oncol Nurs Forum 40 2013 E223 E224 abstract 136314
20. C. Guevremont, A. Alasker, and P.I. Karakiewicz Management of sorafenib, sunitinib, and temsirolimus toxicity in metastatic renal cell carcinoma Curr Opin Support Palliat Care 3 2009 170 179
21. N. Bhojani, C. Jeldres, and J.J. Patard Toxicities associated with the administration of sorafenib, sunitinib, and temsirolimus and their management in patients with metastatic renal cell carcinoma Eur Urol 53 2008 917 930
22. N.S. Turhal, S. Erdal, and S. Karacay Efficacy of treatment to relieve mucositis-induced discomfort Support Care Cancer 8 2000 55 58
23. M. Cummins, and N. Pavlakis The use of targeted therapies in pancreatic neuroendocrine tumours: patient assessment, treatment administration, and management of adverse events Ther Adv Med Oncol 5 2013 286 300
24. M.J. Dodd, S.L. Dibble, and C. Miaskowski Randomized clinical trial of the effectiveness of 3 commonly used mouthwashes to treat chemotherapy-induced mucositis Oral Surg Oral Med Oral Pathol Oral Radiol Endod 90 2000 39 47
25. D.I. Rosenthal, and A. Trotti Strategies for managing radiation-induced mucositis in head and neck cancer Semin Radiat Oncol 19 2009 29 34
26. A. Chan, and R.J. Ignoffo Survey of topical oral solutions for the treatment of chemo-induced oral mucositis J Oncol Pharm Pract 11 2005 139 143
27. J.E. Clarkson, H.V. Worthington, and O.B. Eden Interventions for treating oral mucositis for patients with cancer receiving treatment Cochrane Database Syst Rev 18 2007 CD001973
28. M.M. Cawley, and L.M. Benson Current trends in managing oral mucositis Clin J Oncol Nurs 9 2005 584 592
29. M. Wiseman The treatment of oral problems in the palliative patient J Can Dent Assoc 72 2006 453 458